Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial.
Article in Thorax (March 2023)
The most recent citing publications are shown below. View all 128 publications that cite this research output on Dimensions.
Investigating significant health trends in progressive fibrosing interstitial lung disease (INSIGHTS-ILD): rationale, aims and design of a nationwide prospective registry
Article in BMC Pulmonary Medicine (February 2023)
Differences in Treatment Response in Bronchial Epithelial Cells from Idiopathic Pulmonary Fibrosis (IPF) Patients: A First Step towards Personalized Medicine?
Article in Antioxidants (February 2023)